Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.25, $0.02 better than the analyst estimate of $0.23. Revenue for the quarter came in at $731.1 million versus the consensus estimate of $743.53 million.

GUIDANCE:

Elanco Animal Health sees FY2019 EPS of $1.02-$1.12, versus the consensus of $1.08. Elanco Animal Health sees FY2019 revenue of $3.02-3.08 billion, versus the consensus of $3.13 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.